Enhanced levels and enhanced clonogenic capacity of blood progenitor cells following administration of stem cell factor plus granulocyte colony- stimulating factor to humans

Blood

Volumn 90, Issue 9, 1997, Pages 3378-3389

  Begley, C G ^a   Basser, R ^b   Mansfield, R ^b   Thomson, B ^b   Parker, W R L ^b   Layton, J ^b   To, B ^b   Cebon, J ^b   Sheridan, W P ^b   Fox, R M ^b   Green, M D ^b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT METHIONYL STEM CELL FACTOR; RECOMBINANT STEM CELL FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030783509     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3378     Document Type: Article

References (69)

1. + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74:1905, 1989
2. Haas R, Ho AD, Bredthauer U, Cayeux S, Egerer G, Knauf W, Hunstein W: Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 18:94, 1990
3. Elias AD, Ayash L, Anderson KC, Hunt M, Wheeler C, Schwartz G, Tepler I, Mazanet R, Lynch C, Pap S, Pelaez J, Reich E, Critchlow J, Demetri G, Bibbo J, Schnipper L, Griffin JD, Frei E, Amman KH: Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036, 1992
4. Huan SD, Hester J, Spitzer G, Yau JC, Dunphy FR, Wallerstein RO, Dicke K, Spencer V, LeMaistre CF, Andersson BS, Deisseroth AB, Ventura GJ: Influence of mobilized peripheral blood cells on the hematopoietic recovery by autologous marrow and recombinant human granulocyte-macrophage colony-stimulating factor after high-dose cyclophosphamide, etoposide, and cisplatin. Blood 79:3388, 1992
5. Sheridan WP, Begley CG, Juttner CA, Szer J, To LB, Maher D, McGrath KM, Morstyn G, Fox RM: Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1992
6. Shea TC, Mason JR, Breslin M, Bissent E, Mullen M, Taetle R: Reinfusion and serial measurements of carboplatin-mobilized peripheral-blood progenitor cells in patients receiving multiple cycles of high-dose chemotherapy. J Clin Oncol 12:1012, 1994
7. Sheridan WP, Begley CG, To LB, Grigg A, Szer J, Maher D, Green MD, Rowlings PA, McGrath KM, Cebon J, Dyson P, Watson D, Bayly J, DeLuca E, Tomita D, Hoffman E, Morstyn G, Juttner CA, Fox RM: Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 14:105, 1994
8. Dührsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D: Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients, Blood 72:2074, 1988
9. DeLuca E, Sheridan WP, Watson D, Szer J, Begley CG: Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer 66:893, 1992
10. Baumann I, Testa NG, Lange C, de Wynter E, Luft T, Dexter TM, van Hoef ME, Howell A: Haemopoietic cells mobilised into the circulation by lenograstim as alternative to bone marrow for allogeneic transplants. Lancet 341:369, 1993 (letter)
11. Grigg AP, Roberts AW, Raunow H, Houghton S, Layton JE, Boyd AW, McGrath KM, Maher D: Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437, 1995
12. Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD: Granulocyte-macrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1:1194, 1988
13. Gianni AM, Siena S, Bregni M, Tarella C, Stern AC, Pileri A, Bonadonna G: Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 2:580, 1989
14. Villeval JL, Duhrsen U, Morstyn G, Metcalf D: Effect of recombinant human granulocyte-macrophage colony stimulating factor on progenitor cells in patients with advanced malignancies. Br J Haematol 74:36, 1990
15. Ganser A, Lindemann A, Seipelt G, Ottmann OG, Eder M, Falk S, Herrmann F, Kaltwasser JP, Meusers P, Klausmann M, Frisch J, Schulz G, Mertelsmann R, Hoelzer D: Effects of recombinant human interleukin-3 in aplastic anemia. Blood 76:1287, 1990
16. Ottmann OG, Ganser A, Seipelt G, Eder M, Schulz G, Hoelzer D: Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo. Blood 76:1494, 1990
17. Basser RL, Rusko JEJ, Clarke K, Cebon J, Green MD, Grigg AP, Zalcbcrg J, Cohen B, O'Byrne J, Menchaca DM, Sheridan WP, Fox RM, Begley CG: Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 89:3118, 1997
18. Rasko JEJ, Basser RL, Boyd J, Mansfield R, O'Malley CJ, Hussein S, Berndt MC, Clarke K, O'Byrne J, Sheridan WP, Grigg AP, Begley CG: Multilineage mobilisation of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Br J Haematol 97:871, 1997
19. Cashman J, Eaves AC, Eaves CJ: Regulated proliferation of primitive hematopoietic progenitor cells in long-term human marrow cultures. Blood 66:1002, 1985
20. Miyake K, Weissman IL, Greenberger JS, Kincade PW: Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med 173:599, 1991
21. Hurley RW, McCarthy JR, Verfaillie CM: Direct adhesion to bone marrow stroma via flbronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96:511, 1995
22. Levesque JP, Leavesley DI, Niutta S, Vadas M, Simmons PJ: Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. J Exp Med 181:1805, 1995
23. Galli SJ, Zsebo KM, Geissler EN: The kit ligand, stem cell factor. Adv Immunol 55:1, 1994
24. Sheridan WP, McNiece IK: Stem cell factor, in Armitage JO, Antman KH (eds): High Dose Chemotherapy. Baltimore, MD, Williams and Wilkins, 1996, p 429
25. Bernstein ID, Andrews RG, Zsebo KM: Recombinant human stem cell factor enhances the formation of colonies by CD34+ and CD34+lin- cells, and the generation of colony-forming cell progeny from CD34+lin- cells cultured with interleukin-3, granulocyte colony-stimulating factor, or granulocyte-macrophage colony-stimulating factor. Blood 77:2316, 1991
26. Broxmeyer HE, Cooper S, Lu L, Hangoc G, Anderson D, Cosman D, Lyman SD, Williams DE: Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood 77:2142, 1991
27. de Vries P, Brasel KA, Eisenman JR, Alpert AR, Williams DE: The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med 173:1205, 1991
28. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19:226, 1991
29. Cicuttini FM, Begley CG, Boyd AW: The effect of recombinant stem cell factor (SCF) on purified CD34-positive human umbilical cord blood progenitor cells. Growth Factors 6:31, 1992
30. Andrews RG, Knitter GH, Bartelmez SH, Langley KE, Farrar D, Hendren RW, Appelbaum FR, Bernstein ID, Zsebo KM: Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood 78:1975, 1991
31. Bodine DM, Seidel NE, Zsebo KM, Orlic D: In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82:445, 1993
32. Andrews RG, Bensinger WI, Knitter GH, Bartelmez SH, Longin K, Bernstein ID, Appelbaum FR, Zsebo KM: The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons. Blood 80:2715, 1992
33. Briddell RA, Hartley CA, Smith KA, McNiece IK: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720, 1993
34. Andrews RG, Briddell RA, Knitter GH, Opie T, Bronsden M, Myerson D, Appelbaum FR, McNiece IK: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells. Blood 84:800, 1994
35. de Revel T, Appelbaum FR, Storb R, Schuening F, Nash R, Deeg J, McNiece I, Andrews R, Graham T: Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated clogs. Blood 83:3795, 1994
36. Drize N, Chertkov J, Zander A: Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Exp Hematol 23:1180, 1995
37. Bodine DM, Seidel NE, Gale MS, Nienhuis AW, Orlic D: Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 84:1482, 1994
38. Weaver A, Ryder D, Crowther D, Dexter TM, Testa NG: Increased numbers of long-term culture initiating cells in the apheresis product of patients randomized to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor. Blood 88:3323, 1996
39. Crawford J, Lau D, Erwin R, Rich W, McGuire B, Meyers F: A phase 1 trial of recombinant human stem cell factor (SCF) in patients with advanced non-small cell carcinoma. Proc Am Soc Clin Oncol 12:338a, 1993 (abstr)
40. Demetri G, Costa J, Hayes D, Sledge G, Galli S, Hoffman R, Merica E, Rich W, Harkins B, McGuire B, Gordon ML: A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients with advanced carcinoma pre- and post- chemotherapy (chemo) with cyclophosphamide (C) and doxorubicin (A). Proc Am Soc Clin Oncol 12:367a, 1993 (abstr)
41. Kurtzberg J, Meyers F, McGuire B, Crawford J: Mobilization of peripheral blood progenitor cells in patients given recombinant methionyl human stem cell factor. Proc AACR 34:211 a, 1993 (abstr)
42. Demetri GD, Gordon M, Hoffman R, Hayes DF, Sledge G, Sullivan S, Edwards R, Merica E, Baltiato L, Griffin JD: Effects of recombinant methionyl human stem cell factor on hematopoietic progenitor cells in vivo: Preliminary results from a phase I trial. Proc AACR 34:217a, 1993 (abstr)
43. Tong J, Gordon MS, Srour EF, Cooper RJ, Orazi A, McNiece I, Hoffman R: In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 82:784, 1993
44. Glaspy J, McNiece IK, LeMaistre F, Menchaca D, Briddell R, Lill M, Jones R, Tami J, Morstyn G, Brown S, Shpall EJ: Effects of stem cell factor (rhSCF) and filgrastim on the mobilization of peripheral blood progenitor cells (PBPC) and hematological recovery post transplant: Preliminary phase1/II study results. Br J Haematol 87:156a, 1994 (abstr)
45. Moskowitz C, Stiff P, Gordon M, Gabrilove J, Bayer R, Broun R, Nichols C, Ho AD, Wyres M, Nimer S, McNiece I: The influence of extensive prior chemotherapy on the mobilization of peripheral blood progenitor cells (PBPC) using stem cell factor (rhSCF) and filgrastim (r-metHuG-CSF) and on hematological recovery post cyclophosphamide, BCNU, and VP-16 (CBV) in patients (pts) with relapsed non-Hodgkin's lymphoma (NHL): An interim analysis. Blood 84:107a, 1994 (abstr, suppl 1)
46. Tricot G, Jagannath S, Desikan KR, Siegel D, Munshi N, Olson E, Wyres M, Parker W, Barlogie B: Superior moblization of peripheral blood progenitor cells (PBPC) with r-metHuSCF (SCF) and r-metHUG-CSF (filgrastim) in heavily pretreated multiple myeloma (MM) patients. Blood 88:388a, 1996 (abstr, suppl 1)
47. Basser R, Begley CG, Maher D, To B, Juttner CA, Fox RM, Cebon J, Grigg A, Szer J, Marty J, Sheridan W, Collins J, Russell I, Green MD: The use of peripheral blood progenitor cells (PBPC) mobilized by stem cell factor (SCF) and filgrastim (G-CSF) to support multiple cycles of high-dose chemotherapy in untreated women with poor prognosis breast cancer. Br J Haematol 87:91a, 1994 (abstr)
48. Basser R, Begley CG, Mansfield R, To B, Juttner C, Maher D, Fox R, Cebon J, Szer J, Grigg A, Clark K, Marty J, Menchaca D, Thompson B, Russell I, Collins J, Green M: Mobilization of PBPC by priming with stem cell factor (SCF) before filgrastim compared to concurrent administration. Blood 86:687a, 1995 (abstr, suppl 1)
49. Begley CG, Basser RL, Mansfield R, Maher D, To B, Juttner CA, Fox RM, Cebon J, Grigg A, Szer J, McGrath K, Thomson B, Sheridan W, Menchaca D, Collins J, Russell I, Green MD: Randomized prospective study demonstrating a prolonged effect of SCF with G-CSF (filgrastim) on PBPC in untreated patients: Early results. Blood 84:90a, 1994 (abstr, suppl 1)
50. Begley CG: Human progenitor cell assays, in Morstyn G, Sheridan W (eds): Cell Therapy. New York, NY, Cambridge, 1996
51. Begley CG, Lopez AF, Vadas MA, Metcalf D: The clonal proliferation in vitro of enriched populations of human promyelocytes and myelocytes. Blood 65:951, 1985
52. Begley CG, Metcalf D, Lopez AF, Nicola NA: Fractionated populations of normal human marrow cells respond to both human colony-stimulating factors with granulocyte-macrophage activity. Exp Hematol 13:956, 1985
53. Metcalf D, Begley CG, Johnson GR, Nicola NA, Vadas MA, Lopez AF, Williamson DJ, Wong GG, Clark SC, Wang EA: Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor. Blood 67:37, 1986
54. Burgess AW, Begley CG, Johnson GR, Lopez AF, Williamson DJ, Mermod JJ, Simpson RJ, Schmitz A, DeLamarter JF: Purification and properties of bacterially synthesized human granulocyte-macrophage colony stimulating factor. Blood 69:43, 1987
55. Begley CG. Rasko JEJ, Curtis D, Takagi K, Metcalf D, Hilton D, Roberts B, Nicola NA, Rossner M: Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal. Exp Hematol 24:1247, 1996
56. Basser RL, To B, Begley CG, Juttner CA, Maher DW, Szer J, Cebon J, Collins JP, Russell I, Olver I, Gill PG, Fox RM, Sheridan WP, Green MD: Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells. Clin Cancer Res 1:715, 1995
57. Roberts AW, DeLuca E, Begley CG, Basser R, Grigg AP, Metcalf D: Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 13:512, 1995
58. Moskowitz CH, Stiff P, Gordon MS, McNiece I, Ho AD, Costa JJ, Broun ER, Bayer RA, Wyres M, Hill J, Jelaca-Maxwell K, Nichols CR, Brown SL, Nimer SD, Gabrilove J: Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in Non-Hodgkins lymphoma patients: Results of a phase I/II trial. Blood 89:9, 1997
59. Höcker P, Geissler K, Kurz M, Wagner A, Gerhartl K: Potentiation of GM-CSF or G-CSF induced mobilization of circulating progenitor cells by pretreatment with IL-3 and harvest by apheresis. Int J Artificial Organs 5:25, 1993
60. D'Hondt V, Guillaume T, Humblet Y, Doyen C, Chatelain B, Feyens AM, Staquet P, Osselaer JC. Mull B, Symann M: Tolerance of sequential or simultaneous administration of IL-3 and G-CSF in improving peripheral blood stem cells harvesting following multi-agent chemotherapy: A pilot study. Bone Marrow Transplant 13:261, 1994
61. Tong J, Hoffman R, Siena S, Srour EF, Bregni M, Gianni AM: Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts. Exp Hematol 22:1016, 1994
62. Mullen M, Mealiffe M, Terstappen LW, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: Potential role in allogeneic marrow transplantation. Blood 85:275, 1995
63. Huhn RD, Yurkow EJ, Tushinski R, Clarke L, Sturgill MG, Hoffman R, Sheay W, Cody R, Philipp C, Resta D, George M: Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers. Exp Hematol 24:839, 1996
64. Roberts AW, Metcalf D: Granulocyte colony-stimulating factor induces selective elevations of progenitor cells in the peripheral blood of mice. Exp Hematol 22:1156, 1994
65. Lyman SD, James L, Vanden Bos T, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FA, Maraskovsky E, Farrah J, Foxworth ED, Williams DR, Beckmann P: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells. Cell 75:1157, 1993
66. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Dudd G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Keiner G, Namikawa R, Rennick D, Roncarolo M-G, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
67. Rasko JEJ, Metcalf D, Rossner MT. Begley CG, Nicola NA: The flt3/flk2 ligand: Receptor distribution and action on murine haemopoietic cell survival and proliferation. Leukemia 9:2058, 1995
68. Elwood NJ, Zogos H, Willson T, Begley CG: Retroviral transduction of human progenitor cells: Use of G-CSF plus SCF to mobilize progenitor cells in vivo and stimulation by flt3/flk-2 ligand in vitro. Blood 88:4452, 1996
69. Metcalf D: The hemopoietic colony stimulating factors. Amsterdam, The Netherlands, Elsevier, 1984